COLUMN 1 | COLUMN 2 | COLUMN 3 | COLUMN 4 | COLUMN 5 | COLUMN 6 | COLUMN 7 | COLUMN 8 |
| | | VALUE | SHRS OR | SH/ | PUT/ | INVESTMENT | OTHER | VOTING AUTHORITY |
NAME OF ISSUER | TITLE OF CLASS | CUSIP | (x$1000) | PRN AMT | PRN | CALL | DISCRETION | MANAGER | SOLE | SHARED | NONE |
Abaxis, Inc. | Common | 002567105 | 988 | 22,466 | SH | | SOLE | | 22,466 | 0 | 0 |
AbbVie Inc. | Common | 00287Y109 | 8,932 | 164,156 | SH | | SOLE | | 164,156 | 0 | 0 |
ACADIA Pharmaceuticals Inc. | Common | 004225108 | 18,602 | 562,500 | SH | | SOLE | | 562,500 | 0 | 0 |
Accelerate Diagnostics, Inc. | Common | 00430H102 | 2,340 | 144,625 | SH | | SOLE | | 144,625 | 0 | 0 |
Achillion Pharmaceuticals Inc | Common | 00448Q201 | 3,782 | 547,300 | SH | | SOLE | | 547,300 | 0 | 0 |
Adaptimmune Therapeutics plc | Sponsored ADR | 00653A107 | 3,375 | 281,934 | SH | | SOLE | | 281,934 | 0 | 0 |
Aegerion Pharmaceuticals, Inc. | Common | 00767E102 | 2,802 | 206,000 | SH | | SOLE | | 206,000 | 0 | 0 |
Aegerion Pharmaceuticals, Inc. | Note 2.00% 8/15/19 | 00767EAB8 | 36,801 | 13,000,000 | PRN | | SOLE | | 13,000,000 | 0 | 0 |
Aetna, Inc. | Common | 00817Y108 | 36,317 | 331,931 | SH | | SOLE | | 331,931 | 0 | 0 |
Aetna, Inc. | Common | 00817Y108 | 9,223 | 84,300 | SH | Call | SOLE | | 84,300 | 0 | 0 |
Affimed NV | Common | N01045108 | 1,407 | 228,083 | SH | | SOLE | | 228,083 | 0 | 0 |
Agilent Technologies, Inc. | Common | 00846U101 | 21,822 | 635,650 | SH | | SOLE | | 635,650 | 0 | 0 |
Akorn, Inc. | Common | 009728106 | 24,214 | 849,482 | SH | | SOLE | | 849,482 | 0 | 0 |
Alere, Inc. | Common | 01449J105 | 14,344 | 297,901 | SH | | SOLE | | 297,901 | 0 | 0 |
Alexion Pharmaceuticals, Inc. | Common | 015351109 | 99,590 | 636,805 | SH | | SOLE | | 636,805 | 0 | 0 |
Alexion Pharmaceuticals, Inc. | Common | 015351109 | 2,846 | 18,200 | SH | Call | SOLE | | 18,200 | 0 | 0 |
Alkermes plc | Common | G01767105 | 68,399 | 1,165,818 | SH | | SOLE | | 1,165,818 | 0 | 0 |
Alkermes plc | Common | G01767105 | 9,575 | 163,200 | SH | Call | SOLE | | 163,200 | 0 | 0 |
Allergan plc | Common | G0177J108 | 86,350 | 317,686 | SH | | SOLE | | 317,686 | 0 | 0 |
Allergan plc | Common | G0177J108 | 9,676 | 35,600 | SH | Call | SOLE | | 35,600 | 0 | 0 |
Allergan plc | Preferred Convertible | G0177J116 | 4,717 | 5,000 | SH | | SOLE | | 5,000 | 0 | 0 |
Alliqua BioMedical, Inc. | Common | 019621200 | 5,231 | 1,650,000 | SH | | SOLE | | 1,650,000 | 0 | 0 |
Allscripts Healthcare Solutions, Inc. | Common | 01988P108 | 22,050 | 1,778,200 | SH | | SOLE | | 1,778,200 | 0 | 0 |
Alnylam Pharmaceuticals, Inc. | Common | 02043Q107 | 22,619 | 281,474 | SH | | SOLE | | 281,474 | 0 | 0 |
Alnylam Pharmaceuticals, Inc. | Common | 02043Q107 | 2,371 | 29,500 | SH | Call | SOLE | | 29,500 | 0 | 0 |
Amgen Inc. | Common | 031162100 | 44,489 | 321,640 | SH | | SOLE | | 321,640 | 0 | 0 |
Anacor Pharmaceuticals Inc. | Common | 032420101 | 7,698 | 65,400 | SH | | SOLE | | 65,400 | 0 | 0 |
Anacor Pharmaceuticals Inc. | Common | 032420101 | 7,698 | 65,400 | SH | Call | SOLE | | 65,400 | 0 | 0 |
ARCA biopharma, Inc. | Common | 00211Y407 | 4,032 | 811,227 | SH | | SOLE | | 811,227 | 0 | 0 |
Ardelyx, Inc. | Common | 039697107 | 11,064 | 640,270 | SH | | SOLE | | 640,270 | 0 | 0 |
Auris Medical Holding AG | Common | H03579101 | 7,495 | 2,105,263 | SH | | SOLE | | 2,105,263 | 0 | 0 |
Baxalta Inc. | Common | 07177M103 | 10,071 | 319,600 | SH | | SOLE | | 319,600 | 0 | 0 |
Baxter International, Inc. | Common | 071813109 | 10,499 | 319,600 | SH | | SOLE | | 319,600 | 0 | 0 |
Bellicum Pharmaceutical, Inc. | Common | 079481107 | 872 | 60,000 | SH | | SOLE | | 60,000 | 0 | 0 |
BioDelivery Sciences International, Inc. | Common | 09060J106 | 1,390 | 250,000 | SH | | SOLE | | 250,000 | 0 | 0 |
Biogen Inc. | Common | 09062X103 | 136,329 | 467,183 | SH | | SOLE | | 467,183 | 0 | 0 |
BioMarin Pharmaceutical Inc. | Common | 09061G101 | 60,083 | 570,477 | SH | | SOLE | | 570,477 | 0 | 0 |
BioMarin Pharmaceutical Inc. | Common | 09061G101 | 3,739 | 35,500 | SH | Call | SOLE | | 35,500 | 0 | 0 |
bluebird bio, Inc. | Common | 09609G100 | 8,037 | 93,945 | SH | | SOLE | | 93,945 | 0 | 0 |
bluebird bio, Inc. | Common | 09609G100 | 5,766 | 67,400 | SH | Call | SOLE | | 67,400 | 0 | 0 |
Bristol-Myers Squibb Co. | Common | 110122108 | 31,686 | 535,240 | SH | | SOLE | | 535,240 | 0 | 0 |
Bristol-Myers Squibb Co. | Common | 110122108 | 10,490 | 177,200 | SH | Call | SOLE | | 177,200 | 0 | 0 |
Care Capital Properties, Inc. | Common | 141624106 | 2,777 | 84,316 | SH | | SOLE | | 84,316 | 0 | 0 |
Celgene Corporation | Common | 151020104 | 185,364 | 1,713,634 | SH | | SOLE | | 1,713,634 | 0 | 0 |
Celgene Corporation | Common | 151020104 | 10,092 | 93,300 | SH | Call | SOLE | | 93,300 | 0 | 0 |
Celldex Therapeutics, Inc. | Common | 15117B103 | 3,567 | 338,400 | SH | | SOLE | | 338,400 | 0 | 0 |
Cellectis S.A. | Sponsored ADS | 15117K103 | 4,175 | 158,382 | SH | | SOLE | | 158,382 | 0 | 0 |
Centene Corporation | Common | 15135B101 | 6,508 | 120,000 | SH | | SOLE | | 120,000 | 0 | 0 |
Chimerix Inc. | Common | 16934W106 | 1,826 | 47,800 | SH | | SOLE | | 47,800 | 0 | 0 |
Cidara Therapeutics, Inc. | Common | 171757107 | 636 | 50,000 | SH | | SOLE | | 50,000 | 0 | 0 |
Cigna Corporation | Common | 125509109 | 10,025 | 74,251 | SH | | SOLE | | 74,251 | 0 | 0 |
Cigna Corporation | Common | 125509109 | 10,018 | 74,200 | SH | Call | SOLE | | 74,200 | 0 | 0 |
Community Health Systems, Inc. | Common | 203668108 | 8,963 | 209,572 | SH | | SOLE | | 209,572 | 0 | 0 |
Corsicanto Ltd | Note 3.5% 1/15/32 | 220480AB3 | 13,506 | 14,700,000 | PRN | | SOLE | | 14,700,000 | 0 | 0 |
Cynapsus Therapeutics, Inc. | Common | 23257Y859 | 799 | 49,322 | SH | | SOLE | | 49,322 | 0 | 0 |
DBV Technologies S.A. | Sponsored ADR | 23306J101 | 2,335 | 65,600 | SH | | SOLE | | 65,600 | 0 | 0 |
Dynavax Technologies Corporation | Common | 268158201 | 6,749 | 275,000 | SH | | SOLE | | 275,000 | 0 | 0 |
DepoMed Inc. | Common | 249908104 | 3,770 | 200,000 | SH | | SOLE | | 200,000 | 0 | 0 |
Eli Lilly & Co | Common | 532457108 | 7,169 | 85,667 | SH | | SOLE | | 85,667 | 0 | 0 |
Endo International PLC | Common | G30401106 | 22,192 | 320,321 | SH | | SOLE | | 320,321 | 0 | 0 |
Endologix Inc. | Common | 29266S106 | 6,755 | 551,000 | SH | | SOLE | | 551,000 | 0 | 0 |
Epizyme, Inc. | Common | 29428V104 | 3,301 | 256,700 | SH | | SOLE | | 256,700 | 0 | 0 |
Esperion Therapeutics, Inc. | Common | 29664W105 | 2,425 | 102,800 | SH | | SOLE | | 102,800 | 0 | 0 |
Esperion Therapeutics, Inc. | Common | 29664W105 | 2,425 | 102,800 | SH | Call | SOLE | | 102,800 | 0 | 0 |
Flex Pharma, Inc. | Common | 33938A105 | 2,794 | 232,600 | SH | | SOLE | | 232,600 | 0 | 0 |
Foamix Pharmaceuticals Ltd. | Common | M46135105 | 4,498 | 613,577 | SH | | SOLE | | 613,577 | 0 | 0 |
Forward Pharma A/S | Sponsored ADR | 34986J105 | 3,120 | 132,447 | SH | | SOLE | | 132,447 | 0 | 0 |
Galapagos NV | Sponsored ADR | 36315X101 | 814 | 20,000 | SH | | SOLE | | 20,000 | 0 | 0 |
GenMark Diagnostics, Inc. | Common | 372309104 | 1,693 | 215,149 | SH | | SOLE | | 215,149 | 0 | 0 |
Gilead Sciences, Inc. | Common | 375558103 | 218,122 | 2,221,431 | SH | | SOLE | | 2,506,431 | 0 | 0 |
GlaxoSmithKline Plc | Sponsored ADR | 37733W105 | 10,958 | 285,000 | SH | | SOLE | | 285,000 | 0 | 0 |
Grifols SA | Sponsored ADR | 398438408 | 2,523 | 83,000 | SH | | SOLE | | 83,000 | 0 | 0 |
GW Pharmaceuticals Plc | Sponsored ADS | 36197T103 | 8,589 | 94,000 | SH | | SOLE | | 94,000 | 0 | 0 |
GW Pharmaceuticals Plc | Common | 36197T103 | 3,783 | 41,400 | SH | Call | SOLE | | 41,400 | 0 | 0 |
HCA Holdings, Inc. | Common | 40412C101 | 18,813 | 243,188 | SH | | SOLE | | 243,188 | 0 | 0 |
Healthcare Realty Trust, Inc. | Common | 421946104 | 4,653 | 187,224 | SH | | SOLE | | 187,224 | 0 | 0 |
Heron Therapeutics, Inc. | Common | 427746102 | 5,344 | 219,000 | SH | | SOLE | | 219,000 | 0 | 0 |
Horizon Pharma Plc | Common | G4617B105 | 3,229 | 162,900 | SH | | SOLE | | 162,900 | 0 | 0 |
Horizon Pharma Plc | Common | G4617B105 | 3,229 | 162,900 | SH | Call | SOLE | | 162,900 | 0 | 0 |
Humana, Inc. | Common | 444859102 | 23,145 | 129,300 | SH | | SOLE | | 129,300 | 0 | 0 |
Humana, Inc. | Common | 444859102 | 10,543 | 58,900 | SH | Call | SOLE | | 58,900 | 0 | 0 |
ICON PLC | Common | G4705A100 | 5,110 | 72,000 | SH | | SOLE | | 72,000 | 0 | 0 |
IDEXX Laboratories, Inc. | Common | 45168D104 | 9,827 | 132,352 | SH | | SOLE | | 132,352 | 0 | 0 |
Illumina, Inc. | Common | 452327109 | 52,982 | 301,341 | SH | | SOLE | | 301,341 | 0 | 0 |
Impax Laboratories, Inc. | Common | 45256B101 | 12,136 | 344,683 | SH | | SOLE | | 344,683 | 0 | 0 |
Incyte Corporation | Common | 45337C102 | 97,141 | 880,461 | SH | | SOLE | | 880,461 | 0 | 0 |
Incyte Corporation | Common | 45337C102 | 10,338 | 93,700 | SH | Call | SOLE | | 93,700 | 0 | 0 |
Inotek Pharmaceuticals Corp. | Common | 45780V102 | 3,995 | 425,000 | SH | | SOLE | | 425,000 | 0 | 0 |
Intra-Cellular Therapies, Inc. | Common | 46116X101 | 6,006 | 150,000 | SH | | SOLE | | 150,000 | 0 | 0 |
Ishares Nasdaq Biotechnology ETF | ETF | 464287556 | 17,493 | 57,670 | SH | | SOLE | | 57,670 | 0 | 0 |
Isis Pharmaceuticals, Inc. | Common | 464330109 | 5,942 | 147,000 | SH | | SOLE | | 147,000 | 0 | 0 |
Johnson & Johnson | Common | 478160104 | 87,841 | 940,988 | SH | | SOLE | | 940,988 | 0 | 0 |
Juno Therapeutics, Inc. | Common | 48205A109 | 7,406 | 182,000 | SH | | SOLE | | 182,000 | 0 | 0 |
Karyopharm Therapeutics Inc. | Common | 48576U106 | 9,676 | 918,866 | SH | | SOLE | | 918,866 | 0 | 0 |
Karyopharm Therapeutics Inc. | Common | 48576U106 | 3,337 | 316,900 | SH | Call | SOLE | | 316,900 | 0 | 0 |
Kite Pharma, Inc. | Common | 49803L109 | 351 | 6,300 | SH | | SOLE | | 6,300 | 0 | 0 |
Lexicon Pharmaceuticals, Inc. | Common | 528872302 | 3,801 | 353,900 | SH | | SOLE | | 353,900 | 0 | 0 |
Lexicon Pharmaceuticals, Inc. | Common | 528872302 | 3,801 | 353,900 | SH | Call | SOLE | | 353,900 | 0 | 0 |
LTC Properties Inc. | Common | 502175102 | 10,096 | 236,618 | SH | | SOLE | | 236,618 | 0 | 0 |
MacroGenics, Inc. | Common | 556099109 | 273 | 12,743 | SH | | SOLE | | 12,743 | 0 | 0 |
Mallinckrodt Plc | Common | G5785G107 | 4,655 | 72,800 | SH | | SOLE | | 72,800 | 0 | 0 |
McKesson Corporation | Common | 58155Q103 | 12,557 | 67,862 | SH | | SOLE | | 67,862 | 0 | 0 |
Medical Properties Trust, Inc. | Common | 58463J304 | 17,299 | 1,564,060 | SH | | SOLE | | 1,564,060 | 0 | 0 |
The Medicines Company | Common | 58463J304 | 2,669 | 70,300 | SH | Call | SOLE | | 70,300 | 0 | 0 |
The Medicines Company | Common | 584688105 | 23,698 | 624,300 | SH | | SOLE | | 624,300 | 0 | 0 |
Medivation, Inc. | Common | 58501N101 | 8,730 | 205,400 | SH | | SOLE | | 205,400 | 0 | 0 |
Medtronic PLC | Common | G5960L103 | 13,860 | 207,044 | SH | | SOLE | | 207,044 | 0 | 0 |
Medtronic PLC | Common | G5960L103 | 5,536 | 82,700 | SH | Call | SOLE | | 82,700 | 0 | 0 |
Merck & Co, Inc. | Common | 58933Y105 | 33,639 | 681,097 | SH | | SOLE | | 681,097 | 0 | 0 |
Merrimack Pharmaceuticals, Inc. | Note 4.50% 7/15/20 | 590328AA8 | 2,336 | 1,485,000 | PRN | | SOLE | | 1,485,000 | 0 | 0 |
Merrimack Pharmaceuticals, Inc. | Common | 590328100 | 7,266 | 853,787 | SH | | SOLE | | 853,787 | 0 | 0 |
Molina Healthcare, Inc. | Common | 60855R100 | 23,953 | 347,901 | SH | | SOLE | | 347,901 | 0 | 0 |
Momenta Pharmaceuticals, Inc. | Common | 60877T100 | 2,522 | 153,700 | SH | | SOLE | | 153,700 | 0 | 0 |
Mylan NV | Shares Euro | N59465109 | 81,956 | 2,035,657 | SH | | SOLE | | 2,035,657 | 0 | 0 |
Mylan NV | Shares Euro | N59465109 | 4,751 | 118,000 | SH | Call | SOLE | | 118,000 | 0 | 0 |
Natera, Inc. | Common | 632307104 | 8,835 | 814,300 | SH | | SOLE | | 814,300 | 0 | 0 |
Neurocrine Biosciences, Inc. | Common | 64125C109 | 14,955 | 375,860 | SH | | SOLE | | 375,860 | 0 | 0 |
Novartis AG | Sponsored ADR | 66987V109 | 8,521 | 92,700 | SH | | SOLE | | 92,700 | 0 | 0 |
Novo Nordisk A/S | Sponsored ADR | 670100205 | 15,979 | 294,600 | SH | | SOLE | | 294,600 | 0 | 0 |
Omega Healthcare Investors Inc. | Common | 681936100 | 14,521 | 413,116 | SH | | SOLE | | 413,116 | 0 | 0 |
Paratek Pharmaceuticals, Inc. | Common | 699374302 | 14,489 | 762,581 | SH | | SOLE | | 762,581 | 0 | 0 |
Perrigo Company PLC | Common | G97822103 | 2,972 | 18,900 | SH | | SOLE | | 18,900 | 0 | 0 |
Pfizer, Inc. | Common | 717081103 | 56,610 | 1,802,291 | SH | | SOLE | | 1,802,291 | 0 | 0 |
Physicians Realty Trust | Common | 71943U104 | 18,572 | 1,230,772 | SH | | SOLE | | 1,230,772 | 0 | 0 |
Pieris Pharmaceuticals, Inc. | Common | 720795103 | 7,042 | 3,848,191 | SH | | SOLE | | 3,848,191 | 0 | 0 |
Puma Biotechnology, Inc. | Common | 74587V107 | 7,174 | 95,200 | SH | | SOLE | | 95,200 | 0 | 0 |
Puma Biotechnology, Inc. | Common | 74587V107 | 3,421 | 45,400 | SH | Call | SOLE | | 45,400 | 0 | 0 |
Regeneron Pharmaceuticals, Inc. | Common | 75886F107 | 71,755 | 154,266 | SH | | SOLE | | 154,266 | 0 | 0 |
Sabra Health Care REIT Inc. | Common | 78573L106 | 10,574 | 456,190 | SH | | SOLE | | 456,190 | 0 | 0 |
Sage Therapeutics, Inc. | Common | 78667J108 | 4,139 | 97,800 | SH | | SOLE | | 97,800 | 0 | 0 |
Sage Therapeutics, Inc. | Common | 78667J108 | 3,504 | 82,800 | SH | Call | SOLE | | 82,800 | 0 | 0 |
Sagent Pharmaceuticals, Inc. | Common | 786692103 | 6,278 | 409,500 | SH | | SOLE | | 409,500 | 0 | 0 |
Senior Housing Properties Trust | Common | 81721M109 | 10,862 | 670,504 | SH | | SOLE | | 670,504 | 0 | 0 |
Shire plc | Sponsored ADR | 82481R106 | 10,162 | 49,513 | SH | | SOLE | | 49,513 | 0 | 0 |
Spectrum Pharmaceuticals, Inc. | Note 2.75% 12/15/18 | 84763AAB4 | 4,453 | 5,000,000 | PRN | | SOLE | | 5,000,000 | 0 | 0 |
St Jude Medical, Inc. | Common | 790849103 | 10,190 | 161,510 | SH | | SOLE | | 161,510 | 0 | 0 |
Stryker Corporation | Common | 863667101 | 11,663 | 123,940 | SH | | SOLE | | 123,940 | 0 | 0 |
Supernus Pharmaceuticals, Inc. | Note 7.50% 5/1/19 | 868459AB4 | 5,548 | 2,000,000 | PRN | | SOLE | | 2,000,000 | 0 | 0 |
Tenet Healthcare Corporation | Common | 88033G407 | 6,073 | 164,500 | SH | | SOLE | | 164,500 | 0 | 0 |
TetraLogic Pharmaceuticals Corporation | Note 8.00% 6/15/19 | 88165UAB5 | 2,360 | 4,500,000 | PRN | | SOLE | | 4,500,000 | 0 | 0 |
Tetraphase Pharmaceuticals Inc. | Common | 88165N105 | 1,435 | 192,322 | PRN | | SOLE | | 192,322 | 0 | 0 |
Teva Pharmaceutical Industries Ltd. | ADR | 881624209 | 78,231 | 1,385,594 | SH | | SOLE | | 1,385,594 | 0 | 0 |
Thermo Fisher Scientific Inc. | Common | 883556102 | 10,564 | 86,395 | SH | | SOLE | | 86,395 | 0 | 0 |
Trillium Therapeutics Inc. | Common | 89620X506 | 847 | 65,000 | SH | | SOLE | | 65,000 | 0 | 0 |
Trovagene, Inc. | Common | 897238309 | 3,130 | 550,000 | SH | | SOLE | | 550,000 | 0 | 0 |
Ultragenyx Pharmaceutical Inc. | Common | 90400D108 | 8,514 | 88,400 | SH | | SOLE | | 88,400 | 0 | 0 |
UniQure NV | Common | N90064101 | 2,102 | 102,800 | SH | | SOLE | | 102,800 | 0 | 0 |
UniQure NV | Common | N90064101 | 2,102 | 102,800 | SH | Call | SOLE | | 102,800 | 0 | 0 |
United Therapeutics Corporation | Common | 91307C102 | 23,964 | 182,600 | SH | | SOLE | | 182,600 | 0 | 0 |
UnitedHealth Group, Inc. | Common | 91324P102 | 36,265 | 312,600 | SH | | SOLE | | 312,600 | 0 | 0 |
UnitedHealth Group, Inc. | Common | 91324P102 | 10,406 | 89,700 | SH | Call | SOLE | | 89,700 | 0 | 0 |
Ventas Inc. | Common | 92276F100 | 20,701 | 369,266 | SH | | SOLE | | 369,266 | 0 | 0 |
Verastem, Inc. | Common | 92337C104 | 895 | 500,000 | SH | | SOLE | | 500,000 | 0 | 0 |
Vertex Pharmaceuticals Incorporated | Common | 92532F100 | 105,171 | 1,009,903 | SH | | SOLE | | 1,009,903 | 0 | 0 |
WellCare Health Plans Inc. | Common | 94946T106 | 7,640 | 88,652 | SH | | SOLE | | 88,652 | 0 | 0 |
Welltower, Inc. | Preferred | 95040Q203 | 12,146 | 200,000 | SH | | SOLE | | 200,000 | 0 | 0 |
Wright Medical Group Inc. | Common | 98235T107 | 3,281 | 156,100 | SH | | SOLE | | 156,100 | 0 | 0 |
Xencor, Inc. | Common | 98401F105 | 245 | 20,000 | SH | | SOLE | | 20,000 | 0 | 0 |
Zafgen, Inc. | Common | 98885E103 | 425 | 13,307 | SH | | SOLE | | 13,307 | 0 | 0 |
Zimmer Biomet Holdings, Inc. | Common | 98956P102 | 9,609 | 102,300 | SH | | SOLE | | 102,300 | 0 | 0 |